Antimalarialās, Bio-Solvents & ESG: This Weekās Top Stories
Access to clean, reliable water underpins not only economic stability but also global health outcomes, as the world faces a projected 56% shortfall of freshwater by 2030, according to Ecolab.
The implications of this water crisis extend far beyond business operations, threatening public health infrastructure, sanitation systems and the ability of healthcare facilities to function effectively.
As demand for water rises alongside the growth of AI and digital infrastructure, the health sector faces mounting pressure.
Healthcare facilities, pharmaceutical manufacturing and infection prevention protocols all depend on consistent water access.
In recognition of Earth Day, Ecolab has announced Ecolab Water Navigator IQ, an AI-enabled platform designed to help organisations manage their water performance in ways that could protect both operational continuity and public health outcomes.
KPMG has released its 2025 Healthcare CEO Outlook, presenting a vision of a healthcare sector that is currently undergoing a massive transformation, balancing the promise of innovation against operational pressures.
Through a survey of 110 global healthcare CEOs, KPMG explores how these leaders are navigating a future defined by shifting demands, the necessity for digitalisation and the imperative of long-term sustainability.
This report underscores the critical need for healthcare executives to adopt strategic, data-driven approaches to ensure their systems remain resilient and effective for the communities they serve.
According to the KPMG 2025 Healthcare CEO Outlook, while healthcare CEOs are optimistic about navigating the evolving ESG landscape, there remains a notable gap between their stated ambitions and actual execution.
Colgate-Palmolive is a global leader in consumer products, specialising in oral care, personal care and home care.
Its goal is to reimagine a healthier future for all people, their pets and the planet.
To help achieve this, it has announced its 2030 Sustainability & Social Impact Strategy to create measurable results and value.
Colgate-Palmolive’s 2030 Strategy is a five-year roadmap that aims to create long-term resilience and growth while supporting the communities in which it operates.
Children under five account for approximately 75% of all malaria deaths in Africa, according to the World Health Organization (WHO).
Novartis has announced that WHO has prequalified Coartem Baby, the first and only antimalarial developed specifically for newborns and young infants weighing from two to five kg.
The antimalarial is developed through a collaboration between Novartis and Medicines for Malaria Venture (MMV), representing a significant advancement in the global response to malaria.
The treatment helps to address a critical gap in malaria care for infants.
The pharmaceutical and life sciences industry is continuously being reshaped by sustainability goals alongside strict manufacturing and analytical performance requirements.
Advances in green chemistry and bio-based inputs are now influencing how essential laboratory materials are produced.
One of the latest developments in this space is Merck Group’s introduction of a bio-based solvent portfolio for high-performance liquid chromatography (HPLC).
This innovation reflects a broader shift toward reducing environmental impact without compromising precision in healthcare and pharmaceutical workflows.
